After much confusion, especially with the Sinovac vaccine results, The Brazilian National Health Surveillance Agency (Anvisa) approved the emergency use […]
Sinovac Life Sciences Co., Ltd. (Sinovac), a subsidiary of Sinovac, has secured $500 million in funding for further development, capacity […]
A Chinese firm, known as Sinovac, one of the leading COVID-19 vaccine developer contenders, recently revealed results from a peer-reviewed […]
TrialSite recently reported that the Brazilian drug regulatory authority has halted the Sinovac (CoronaVac) COVID-19 vaccine trial, however days later […]
Sao Paulo state government in Brazil has requested from Brazil’s national health regulator, Anvisa, to register CoronaVac, the vaccine candidate developed […]
Thus far, Indonesian authorities report the relatively smooth running of the Phase 3 Sinovac COVID-19 clinical trial vaccine candidate. Conducted […]
Indonesia’s Bio Farma, a state-run pharmaceutical company, plans to produce 100 million doses of COVID-19 vaccine product developed by Sinovac. In […]
Sinovac Biotech Ltd. (“Sinovac”) (Nasdaq: SVA), a Chinese biopharmaceutical company developing a COVID-19 vaccine candidate (CoronaVac), announced that its Brazilian […]
Sinovac Biotech Ltd (Sinovac) (NASDAQ: SVA) is a Chinese biotech company vying for a leading position in the race to develop […]
Rodrigo Duterte, the controversial President of the Philippines, hasn’t really embraced, nor even appreciated, the past good relations between the […]
